Boston Scientific Corporation (NYSE:BSX) closed its last session at $23.90 with the change of +1.01%. The market capitalization of the company is $32.43B with an average Volume of 11.47 million shares. The stock currently has its 52-Week High range of $23.97 and 52-week low range of $14.18. The Price to Book (P/B) ratio stands at 4.96. The stock traded total quantity of 6.86 million shares.
For the current Fiscal Quarter, 27 analysts have given an average earnings per share forecast of $0.27. The Low Earnings per share estimate of the current Quarter is $0.26 and High Estimate is set at $0.27 according to these Analysts opinions. The Previous Year EPS of this Quarter is $0.22.
According to 24 analysts, an average sales Estimate of the current Fiscal quarter is $2.05B. The lower sales estimate is $2.02B and higher sales estimate is $2.08B according to these Analysts thoughts.
The Company currently has Highest Price Target of $27.5 and Lowest Price Target of $21. It has Median Price Targets of $25. Mean price target is set at $24.54 after consensus analysis of 26 brokers.
When having look at Recommendation Trends of the analysts polled at Thomson First call, for the Current month 8 analysts have assigned this stock as Strong Buy where 14 assigned Buy, 6 analysts believe it’s a Hold, 0 said Underperform and 0 assigned Sell rating.
ImmunoGen, Inc. (NASDAQ:IMGN) ended its last trade at $3.20 with the move of +2.56%. The company has market value of $278.64M with the total traded volume of 1.38 million. The stock currently has its 52-Week top value of $19.43 and 52-week down value of $2.96. . Its previous closing price was recorded at $3.12.
For the current Fiscal Quarter, 9 analysts have given an Average earnings estimate of $-0.39 per share. According to the Analysts, the Low Estimate Earnings of the current Quarter is $-0.42 while High Estimate is $-0.28. The Previous Year EPS of this Quarter is $-0.35.
According to 9 analysts, an Average Revenue Estimate of the current Fiscal quarter is $16.86M. According to them, the Low Revenue estimate is $14.91M and High Revenue estimate is $18.65M.